SMMT
NASDAQ · Biotechnology
Summit Therapeutics Inc
$16.90
-0.95 (-5.32%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
-11.52%
YTD
-3.54%
Open$18.40
Previous Close$17.85
Day High$18.42
Day Low$16.64
52W High$29.23
52W Low$12.07
Volume—
Avg Volume6.76M
Market Cap14.14B
P/E Ratio—
EPS$-1.12
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$16.75
Above
SMA 200
$20.83
Below
RSI (14)
54
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Buy
24 analysts
Price Target
+1,060.2% upside
Current
$16.90
$16.90
Target
$196.08
$196.08
$141.53
$196.08 avg
$244.39
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.10B | 1.08B | 883.89M |
| Net Income | 169.72M | 168.86M | 142.65M |
| Profit Margin | 15.4% | 15.6% | 16.1% |
| EBITDA | 286.46M | 306.19M | 235.37M |
| Free Cash Flow | 170.10M | 157.58M | 108.43M |
| Rev Growth | -3.6% | +10.5% | -9.8% |
| Debt/Equity | 1.16 | 1.05 | 1.18 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.48 | +0.20% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $393.16 | +1.95% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.56 | +0.30% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $510.72 | +0.47% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $798.17 | +1.70% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $244.32 | +1.99% | 40.0 | 32.33B |